(±)9-HpODE
Based on 1 Customer Validation
(±)9-HpODE is a long chain lipid hydroperoxide, is a product of linoleic acid peroxidation. (±)9-HpODE can induce oxidation of intracellular glutathione (GSH). (±)9-HpODE also exhibits antimicrobial activity against various fungal and bacterial pathogens.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.9%
- CAS No.: 5502-91-0
- Formule: C18H32O4
- Masse moléculaire:312.44
-
Stockage:
Solution, -20°C, 2 years
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-110406A
(±)13-HpODEHydroperoxides Racemic -
HY-110406
13(S)-HPODE -
HY-N7781
(-)-(E)-GuggulsteroneFXR Antagonist -
HY-138166
Rosuvastatin lactoneRosuvastatin Metabolite -
HY-N7848
LinoleamideLinoleamide -
HY-131310
9(S)-HpOTrEUnsaturated Fatty Acid -
HY-118828A
(9S,13R)-12-Oxo phytodienoic acidmPGES-1 Inhibitor -
HY-120891
trans-EKODE-(E)-IbPeroxide -
HY-113545A
(±)9-HODERacemate -
HY-118149
9(S)-HpODE -
HY-113978
6-FormylpterinXanthine Oxidase Inhibitor -
HY-N7781R
(-)-(E)-Guggulsterone (Standard)Analytical Standard
Voir tous les produits spécifiques à Isoform Parasite
More
Activité biologique
Description
In Vitro
(±)9-HpODE (1-25 μM; 0-30 min) induces oxidation of intracellular glutathione (GSH) and with no cytotoxicity in BEAS-2B cells[1].
(±)9-HpODE (25 μM; 0-20 min) induces GSH oxidation is independent of secondary products or H2O2[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 5502-91-0
-
Appearance Liquid
-
Masse moléculaire 312.44
-
Formule C18H32O4
-
Color Colorless to light yellow
-
SMILES
OC(CCCCCCCC(OO)/C=C/C=C\CCCCC)=O
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Solution, -20°C, 2 years
Protocole
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Pureté et documentation
-
Fiche technique (262 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instruction de manipulation (2659 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
(±)9-HpODE Related Classifications
HY-118149A Related Classifications
Powered by Bioz